24 results
424B5
NRIX
Nurix Therapeutics Inc
12 Apr 24
Prospectus supplement for primary offering
5:10pm
, the business combination is approved by the board of directors of the corporation and authorized at an annual or special meeting of stockholders … independent director (as defined in our amended and restated bylaws) or our President, thus prohibiting a stockholder from calling a special meeting
424B5
NRIX
Nurix Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:06pm
at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66.67% of the outstanding voting stock … prohibiting a stockholder from calling a special meeting. These provisions might delay the ability of our stockholders to force consideration of a proposal
8-K
EX-3.1
NRIX
Nurix Therapeutics Inc
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
of the Corporation (as the same may be amended and/or restated from time to time, the “Certificate of Incorporation”). The special meeting may be held either … transacted at any special meeting of stockholders shall be limited to matters relating to the purpose or purposes stated in the notice of the meeting
424B5
NRIX
Nurix Therapeutics Inc
8 Jul 22
Prospectus supplement for primary offering
4:10pm
at an annual or special meeting of stockholders, and not by
written consent, by the affirmative vote of at least 66.67% of the outstanding voting stock … prohibiting a stockholder from calling a special meeting. These provisions might delay the ability of our stockholders to force consideration of a proposal
424B5
NRIX
Nurix Therapeutics Inc
8 Jul 22
Prospectus supplement for primary offering
4:09pm
at an annual or special meeting of stockholders, and not by
written consent, by the affirmative vote of at least 66.67% of the outstanding voting stock … prohibiting a stockholder from calling a special meeting. These provisions might delay the ability of our stockholders to force consideration of a proposal
S-3ASR
t7mxj1hqm5q j1csa8kp
4 Aug 21
Automatic shelf registration
4:11pm
424B4
1baa xzfnd0vg5
5 Mar 21
Prospectus supplement with pricing info
4:07pm
DRS
f93az pollqhl
22 Feb 21
Draft registration statement
12:00am
10-K
EX-4.3
viz3fzle8md0smscky7y
16 Feb 21
Annual report
4:11pm
10-Q
EX-3.1
xk9ty wyzij
14 Oct 20
Quarterly report
4:02pm
10-Q
EX-3.2
v1xz h3hos
14 Oct 20
Quarterly report
4:02pm
424B4
pt8d7lkks k7fawbn
24 Jul 20
Prospectus supplement with pricing info
4:06pm
S-1
EX-3.1
4bc5spz
2 Jul 20
IPO registration
4:04pm
S-1
EX-3.3
mg3swjw
2 Jul 20
IPO registration
4:04pm